The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials (Q2475730): Difference between revisions

From MaRDI portal
Added link to MaRDI item.
ReferenceBot (talk | contribs)
Changed an Item
 
(3 intermediate revisions by 3 users not shown)
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2062420969 / rank
 
Normal rank
Property / Wikidata QID
 
Property / Wikidata QID: Q59901647 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Surrogate Marker Evaluation from an Information Theory Perspective / rank
 
Normal rank
Property / cites work
 
Property / cites work: Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements / rank
 
Normal rank
Property / cites work
 
Property / cites work: Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints / rank
 
Normal rank
Property / cites work
 
Property / cites work: Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points / rank
 
Normal rank
Property / cites work
 
Property / cites work: The evaluation of surrogate endpoints. / rank
 
Normal rank
Property / cites work
 
Property / cites work: Criteria for the Validation of Surrogate Endpoints in Randomized Experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: The validation of surrogate endpoints in meta-analyses of randomized experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence / rank
 
Normal rank
Property / cites work
 
Property / cites work: Choice of units of analysis and modeling strategies in multilevel hierarchical models / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4023085 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Modelling Progression of CD4-Lymphocyte Count and Its Relationship to Survival Time / rank
 
Normal rank
Property / cites work
 
Property / cites work: On meta-analytic assessment of surrogate outcomes / rank
 
Normal rank
Property / cites work
 
Property / cites work: General class of covariance structures for two or more repeated factors in longitudinal data analysis / rank
 
Normal rank
Property / cites work
 
Property / cites work: Survival models for heterogeneous populations derived from stable distributions / rank
 
Normal rank
Property / cites work
 
Property / cites work: Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Mathematical Theory of Communication / rank
 
Normal rank
Property / cites work
 
Property / cites work: Inferences on the Association Parameter in Copula Models for Bivariate Survival Data / rank
 
Normal rank
Property / cites work
 
Property / cites work: Simplified hierarchical linear models for the evaluation of surrogate endpoints / rank
 
Normal rank
Property / cites work
 
Property / cites work: Linear mixed models for longitudinal data / rank
 
Normal rank

Latest revision as of 17:58, 27 June 2024

scientific article
Language Label Description Also known as
English
The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
scientific article

    Statements

    The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    11 March 2008
    0 references
    hierarchical model
    0 references
    likelihood reduction factor
    0 references
    meta-analysis
    0 references
    surrogate threshold effect
    0 references
    information-theoretic unification
    0 references
    0 references

    Identifiers